VOR33,gemtuzumab ozogamicin
Vor Biopharma,UCB Pharmaceuticals,pfizer
['aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)']
vor bio reports successful primary engraftment of trem-cel in first 5 aml patients in phase 1/2a vbp101 study. $vor #biotech #eha2023 #positive 
Real-time news analysis & sentiment scoring for the stocks in the Nasdaq100
Powered by @streetbeat_com of @SP500Tracker
Disclosure: https://t.co/ixCFGXlG3M